CY2086B1 - Process for producing n-amino-1-hydroxy-alkyl-idene-1,1-bisphosphonic acids - Google Patents
Process for producing n-amino-1-hydroxy-alkyl-idene-1,1-bisphosphonic acidsInfo
- Publication number
- CY2086B1 CY2086B1 CY9800001A CY9800001A CY2086B1 CY 2086 B1 CY2086 B1 CY 2086B1 CY 9800001 A CY9800001 A CY 9800001A CY 9800001 A CY9800001 A CY 9800001A CY 2086 B1 CY2086 B1 CY 2086B1
- Authority
- CY
- Cyprus
- Prior art keywords
- producing
- amino
- idene
- hydroxy
- alkyl
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 150000007513 acids Chemical class 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11175193A | 1993-08-25 | 1993-08-25 | |
US23964094A | 1994-05-09 | 1994-05-09 | |
US08/286,151 US5510517A (en) | 1993-08-25 | 1994-08-04 | Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
CY2086B1 true CY2086B1 (en) | 2002-04-05 |
Family
ID=27381051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY9800001A CY2086B1 (en) | 1993-08-25 | 1998-04-09 | Process for producing n-amino-1-hydroxy-alkyl-idene-1,1-bisphosphonic acids |
Country Status (25)
Country | Link |
---|---|
US (1) | US5510517A (xx) |
EP (1) | EP0715631B1 (xx) |
JP (1) | JP3675818B2 (xx) |
KR (1) | KR100261202B1 (xx) |
CN (2) | CN1067079C (xx) |
AT (1) | ATE160352T1 (xx) |
AU (2) | AU692468B2 (xx) |
BR (1) | BR9407563A (xx) |
CA (1) | CA2169561C (xx) |
CY (1) | CY2086B1 (xx) |
CZ (1) | CZ290185B6 (xx) |
DE (1) | DE69406936T2 (xx) |
DK (1) | DK0715631T3 (xx) |
ES (1) | ES2109731T3 (xx) |
FI (1) | FI115526B (xx) |
GR (1) | GR3025450T3 (xx) |
HK (1) | HK1008883A1 (xx) |
HR (1) | HRP940479B1 (xx) |
HU (1) | HU217362B (xx) |
LV (1) | LV12189B (xx) |
NZ (1) | NZ273458A (xx) |
RO (1) | RO115524B1 (xx) |
RU (1) | RU2154647C2 (xx) |
SI (1) | SI0715631T1 (xx) |
WO (1) | WO1995006052A1 (xx) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5449819A (en) * | 1994-06-06 | 1995-09-12 | Merck & Co., Inc. | Process for removing waste pox, alendronate and its by products |
US5589691A (en) * | 1994-06-06 | 1996-12-31 | Merck & Co., Inc. | Process for recovery and recycle of methanesulfonic acid and phosphorous acid |
TR199900730T2 (xx) * | 1996-10-04 | 1999-07-21 | Merck & Co., Inc | S�v� alendronat form�lasyonlar� |
CA2197267C (en) * | 1997-02-11 | 2000-02-08 | Yong Tao | Process for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
GB9800452D0 (en) * | 1998-01-10 | 1998-03-04 | Albright & Wilson | Preparation of phosphonic acid derivatives |
EP1088333A4 (en) | 1998-06-24 | 2005-08-10 | Merck & Co Inc | METHOD AND COMPOSITIONS FOR CONNECTING OSTEOPROSIS |
US20030078211A1 (en) * | 1998-06-24 | 2003-04-24 | Merck & Co., Inc. | Compositions and methods for inhibiting bone resorption |
US6331533B1 (en) | 1998-11-16 | 2001-12-18 | Merck & Co., Inc. | Method for inhibiting dental resorptive lesions |
ES2153794B1 (es) * | 1999-08-06 | 2001-10-16 | Medichem Sa | Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada. |
US6562974B2 (en) | 2000-02-01 | 2003-05-13 | The Procter & Gamble Company | Process for making geminal bisphosphonates |
US6410520B2 (en) | 2000-02-01 | 2002-06-25 | The Procter & Gamble Company | Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
ITMI20020908A1 (it) * | 2002-04-29 | 2003-10-29 | Chemi Spa | Processo di preparazione di sodio alendronato |
ES2532393T3 (es) * | 2002-05-10 | 2015-03-26 | F. Hoffmann-La Roche Ag | Acidos bisfosfónicos para tratamiento y prevención de osteoporosis |
US7038083B2 (en) * | 2002-05-17 | 2006-05-02 | Teva Pharmaceutical Industries, Ltd. | Process for making bisphosphonic acids using diluents other than halogenated hydrocarbons |
EP1513523A1 (en) * | 2002-06-06 | 2005-03-16 | Merck Frosst Canada & Co. | 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases |
JP4485117B2 (ja) * | 2002-06-27 | 2010-06-16 | 日東電工株式会社 | 保護剥離用フィルム |
JP2006504679A (ja) * | 2002-08-28 | 2006-02-09 | メルク フロスト カナダ アンド カンパニー | 緑内障の治療においてep4受容体作動薬として使用するためのオキサゾリジン−2−オンおよびチアゾリジン−2−オン誘導体 |
US20040138180A1 (en) * | 2002-10-03 | 2004-07-15 | Barr Laboratories, Inc. | Bisphosphonate composition and process for the preparation thereof |
US20040206932A1 (en) * | 2002-12-30 | 2004-10-21 | Abuelyaman Ahmed S. | Compositions including polymerizable bisphosphonic acids and methods |
CA2535556C (en) * | 2003-08-12 | 2014-01-07 | 3M Innovative Properties Company | Self-etching dental compositions and methods |
CA2535359A1 (en) | 2003-08-21 | 2005-03-03 | Merck Frosst Canada Ltd. | Cathepsin cysteine protease inhibitors |
WO2005027921A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate |
US20050181043A1 (en) * | 2004-02-12 | 2005-08-18 | Indranil Nandi | Alendronate salt tablet compositions |
UA87854C2 (xx) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-бензил)-2-фенілбутанаміди як модулятори рецептора андрогену$n-(2-бензил)-2-фенилбутанамиды как модуляторы рецептора андрогена |
US8465284B2 (en) * | 2004-07-08 | 2013-06-18 | 3M Innovative Properties Company | Dental methods, compositions, and kits including acid-sensitive dyes |
WO2006020760A1 (en) * | 2004-08-11 | 2006-02-23 | 3M Innovative Properties Company | Self-adhesive compositions including a plurality of acidic compounds |
PL1855674T3 (pl) | 2005-03-02 | 2015-01-30 | Merck Sharp & Dohme | Kompozycja do hamowania katepsyny K |
EP1883644A2 (en) * | 2005-05-06 | 2008-02-06 | Medichem, S.A. | Process of making geminal bisphosphonic acids and pharmaceutically acceptable salts and/or hydrates thereof |
US8003820B2 (en) | 2005-10-20 | 2011-08-23 | Dr. Reddy's Laboratories Limited | Process for preparing bisphosphonic acids |
AR058168A1 (es) * | 2005-11-07 | 2008-01-23 | Merck & Co Inc | Sintesis del alendronato de sodio trihidratado |
WO2007083240A2 (en) | 2006-01-20 | 2007-07-26 | Aurobindo Pharma Limited | An improved process for the preparation of bisphosphonic acids |
EP1987046A1 (en) * | 2006-02-20 | 2008-11-05 | Alembic Limited | An improved process for the preparation of biphosphonic derivatives |
CN101557791B (zh) | 2006-12-13 | 2013-05-22 | 3M创新有限公司 | 使用具有酸性组分和可光漂白染料的牙科用组合物的方法 |
WO2008157050A1 (en) * | 2007-06-19 | 2008-12-24 | Albemarle Corporation | Processes for manufacturing bisphosphonic acids |
PL2222636T3 (pl) | 2007-12-21 | 2014-04-30 | Ligand Pharm Inc | Selektywne modulatory receptorów androgenowych (SARM) i ich zastosowania |
WO2010003704A2 (en) | 2008-07-11 | 2010-01-14 | Synthon B.V. | Process for making 1-hydroxyalkylidene-1,1-biphosphonic acids |
EP2192126B1 (en) | 2008-11-26 | 2013-03-27 | Synthon B.V. | Process for making zoledronic acid |
US20100130746A1 (en) * | 2008-11-26 | 2010-05-27 | Martin Kas | Process for Making Zoledronic Acid |
WO2011023280A1 (en) | 2009-08-28 | 2011-03-03 | Synthon B.V. | Process for making 1-hydroxyalkylidene-1,1-biphosphonic acids |
IN2012DN03448A (xx) | 2009-10-26 | 2015-10-23 | Warner Chilcott Co Llc | |
CA2738045C (en) | 2010-05-28 | 2019-02-19 | Simon Fraser University | Conjugate compounds, methods of making same, and uses thereof |
TR201903835T4 (tr) | 2010-12-06 | 2019-04-22 | Effrx Pharmaceuticals Sa | Hızlı çözünme özelliklerine sahip stabil efervesan bifosfonat formülasyonları. |
WO2012112363A1 (en) | 2011-02-14 | 2012-08-23 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
FI20115315A0 (fi) * | 2011-04-01 | 2011-04-01 | Itae Suomen Yliopisto | Menetelmä metallien keräämiseksi |
WO2015051479A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
AU2014332250B2 (en) | 2013-10-08 | 2018-07-19 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
WO2015120580A1 (en) | 2014-02-11 | 2015-08-20 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
US9650414B1 (en) | 2014-05-30 | 2017-05-16 | Simon Fraser University | Dual-action EP4 agonist—bisphosphonate conjugates and uses thereof |
EP3148587B1 (en) | 2014-05-30 | 2021-02-24 | Pfizer Inc | Carbonitrile derivatives as selective androgen receptor modulators |
WO2016199111A1 (en) | 2015-06-12 | 2016-12-15 | Simon Fraser University | Amide-linked ep4 agonist-bisphosphonate compounds and uses thereof |
EP3827010A4 (en) | 2018-07-23 | 2022-03-16 | Brise Pharmaceuticals Co., Ltd. | BISPHOSPHONATE-DRUG CONJUGATES |
CN109456363A (zh) * | 2018-11-01 | 2019-03-12 | 南京海纳医药科技股份有限公司 | 一种米诺膦酸工艺杂质的制备方法 |
WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3016289A1 (de) * | 1980-04-28 | 1981-10-29 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren |
DD216465A1 (de) * | 1983-07-01 | 1984-12-12 | Agrochemie Piesteritz 4602 Wit | Verfahren zur herstellung substituierter alkanphosphonsaeuren |
US4922007A (en) * | 1989-06-09 | 1990-05-01 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
US5019651A (en) * | 1990-06-20 | 1991-05-28 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof |
-
1994
- 1994-08-04 US US08/286,151 patent/US5510517A/en not_active Expired - Lifetime
- 1994-08-24 EP EP94927234A patent/EP0715631B1/en not_active Expired - Lifetime
- 1994-08-24 CZ CZ1996542A patent/CZ290185B6/cs not_active IP Right Cessation
- 1994-08-24 CA CA002169561A patent/CA2169561C/en not_active Expired - Fee Related
- 1994-08-24 NZ NZ273458A patent/NZ273458A/en not_active IP Right Cessation
- 1994-08-24 RU RU96107773/04A patent/RU2154647C2/ru active
- 1994-08-24 DE DE69406936T patent/DE69406936T2/de not_active Expired - Lifetime
- 1994-08-24 AT AT94927234T patent/ATE160352T1/de active
- 1994-08-24 ES ES94927234T patent/ES2109731T3/es not_active Expired - Lifetime
- 1994-08-24 HU HU9600429A patent/HU217362B/hu unknown
- 1994-08-24 AU AU76743/94A patent/AU692468B2/en not_active Expired
- 1994-08-24 KR KR1019997012458A patent/KR100261202B1/ko not_active IP Right Cessation
- 1994-08-24 HR HR940479A patent/HRP940479B1/xx not_active IP Right Cessation
- 1994-08-24 RO RO96-00335A patent/RO115524B1/ro unknown
- 1994-08-24 DK DK94927234.8T patent/DK0715631T3/da active
- 1994-08-24 BR BR9407563A patent/BR9407563A/pt not_active IP Right Cessation
- 1994-08-24 SI SI9430097T patent/SI0715631T1/xx unknown
- 1994-08-24 CN CN94193725A patent/CN1067079C/zh not_active Expired - Lifetime
- 1994-08-24 WO PCT/US1994/009620 patent/WO1995006052A1/en active IP Right Grant
- 1994-08-24 JP JP50775895A patent/JP3675818B2/ja not_active Expired - Lifetime
-
1996
- 1996-02-23 FI FI960851A patent/FI115526B/fi not_active IP Right Cessation
-
1997
- 1997-11-20 GR GR970402796T patent/GR3025450T3/el unknown
-
1998
- 1998-04-09 CY CY9800001A patent/CY2086B1/xx unknown
- 1998-08-03 HK HK98109618A patent/HK1008883A1/xx not_active IP Right Cessation
- 1998-08-12 AU AU79937/98A patent/AU714996B2/en not_active Expired
- 1998-10-12 LV LVP-98-213A patent/LV12189B/en unknown
-
2000
- 2000-08-03 CN CNB001225669A patent/CN1211392C/zh not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2086B1 (en) | Process for producing n-amino-1-hydroxy-alkyl-idene-1,1-bisphosphonic acids | |
EP0638599A3 (de) | Verfahren zur Herstellung von Polyacetalen. | |
EP0661325A3 (en) | Process for the continuous preparation of lactide copolymer. | |
AU4153193A (en) | Hydroformylation process for producing 1,6-hexanedials | |
HUP9901198A3 (en) | Process for producing l-amino acids | |
HUP9600903A2 (en) | Copolymers based on oxy-alkylene-glycol-alkenyl-ether and unsaturated dicarboxylic acid derivative, process for producing thereof and the use thereof | |
EP0603865A3 (en) | Process for the production of alanines. | |
EP0650994A3 (en) | Process for the preparation of films of aliphatic copolyesters. | |
SG70985A1 (en) | Process for producing 1,4-dienes | |
EP0592072A3 (en) | Process computer control system. | |
EP0614870A3 (en) | Process for the preparation of optically active aldehydes. | |
SG43779A1 (en) | Process for producing 1,4-dicyano-2-butene | |
MY114864A (en) | Process for producing n-amino-1-hydroxy-alkyl-idene-1, 1-bisphosphonic acids | |
EP0592881A3 (en) | Process for the production of optically active gamma-hydroxyketones. | |
AU7438194A (en) | Process for producing spunbonded webs | |
AU6993591A (en) | Process for producing n-phosphonomethylglycine | |
EP0654533A3 (en) | Process for the preparation of D-lactic acid and L-lactamide. | |
GB9614359D0 (en) | Process for producing c2-substituted optically active 2,3-dihydro-4h-pyran-4-one | |
EP0624654A3 (de) | Verfahren zur Herstellung von Leder aus Tierhäuten. | |
EP0645195A3 (de) | Verfahren zur Herstellung von Sonotroden. | |
EP0621288A3 (en) | Process for the production of polyethylene. | |
EP0613620A3 (en) | Process for the production of butter-like spreadable fat. | |
EP0644193A3 (en) | Process for preparing 2-acetylamino-6-chloropurine. | |
EP0566030A3 (en) | Process for the preparation of optically active olefins. | |
EP0597297A3 (en) | Process for the production of methyl alpha-hydroxyisobutyrate. |